BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) bearing homologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results